Articles written by: Henry Smith

Allied Group Limited (0373) Plunged -1.08% on Apr 12

Shares of Allied Group Limited (HKG:0373) last traded at 46, representing a move of -1.08%, or -0.5 per share, on volume of 8,000 shares. After opening the trading day at 46.1, shares of Allied Group Limited traded in a close range. Allied Group Limited currently has a total float of […]

NauticAWT Limited (42D) Is Yet to See Trading Action on Apr 12

Shares of NauticAWT Limited (SGX:42D) closed at 0.028 yesterday. NauticAWT Limited currently has a total float of 212.32 million shares and on average sees shares exchange hands each day. The stock now has a 52-week low of 0.018 and high of 0.028. Singapore Exchange (SGX): Asia’s Rising Exchange Giant Singapore […]

Opiant Pharmaceuticals Inc. (OPNT)’s Financial Results Comparing With Regeneron Pharmaceuticals Inc. (NASDAQ:REGN)

Opiant Pharmaceuticals Inc. (NASDAQ:OPNT) and Regeneron Pharmaceuticals Inc. (NASDAQ:REGN), are influenced by compare since they are both players in the Biotechnology. These factors are particularly influence the institutional ownership, profitability, risk, dividends, analyst recommendations, earnings and valuation of the two firms. Valuation & Earnings Gross Revenue Price/Sales Ratio Net Income […]

DiaMedica Therapeutics Inc. (DMAC) and Akebia Therapeutics Inc. (NASDAQ:AKBA) Contrasting side by side

As Biotechnology businesses, DiaMedica Therapeutics Inc. (NASDAQ:DMAC) and Akebia Therapeutics Inc. (NASDAQ:AKBA), are affected by contrast. This especially applies to their institutional ownership, profitability, analyst recommendations, risk, dividends, earnings and valuation. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio DiaMedica Therapeutics Inc. N/A 87.76 […]

Comparing of Aptose Biosciences Inc. (APTO) and Aravive Inc. (NASDAQ:ARAV)

As Biotechnology companies, Aptose Biosciences Inc. (NASDAQ:APTO) and Aravive Inc. (NASDAQ:ARAV) are our subject to contrast. And more specifically their profitability, analyst recommendations, risk, dividends, earnings and valuation, institutional ownership. Valuation & Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Aptose Biosciences Inc. N/A 0.00 28.87M […]

Klabin S.A. (KLBN3) Moves Up 2.33% on Apr 11

Shares of Klabin S.A. (BVMF:KLBN3) last traded at 4.84, representing a move of 2.33%, or 0.11 per share, on volume of 107,800 shares. After opening the trading day at 4.73, shares of Klabin S.A. traded in a close range. Klabin S.A. currently has a total float of 3.98 billion shares […]

Histogenics Corporation (HSGX) and Alector Inc. (NASDAQ:ALEC) Comparing side by side

Both Histogenics Corporation (NASDAQ:HSGX) and Alector Inc. (NASDAQ:ALEC) compete on a level playing field in the Biotechnology industry. We will evaluate their performance with regards to institutional ownership, earnings and valuation, profitability, risk, dividends, analyst recommendations. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio […]

Boost ShortDAX 3x Daily ETP (3DES) Dips -0.78% on Apr 11

Shares of Boost ShortDAX 3x Daily ETP (LON:3DES) last traded at 6.35, representing a move of -0.78%, or -0.05 per share, on volume of 21,442 shares. After opening the trading day at 6.44, shares of Boost ShortDAX 3x Daily ETP traded in a close range. Boost ShortDAX 3x Daily ETP […]